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S100 proteins are low molecular weight Ca2+-binding proteins.
They are thought to activate target proteins and therefore influence
cellular response along the calcium signal transduction pathway
(Zimmer et al, 1995; Shäfer and Heizmann, 1996). Among these
S100 proteins, S100A6 (also known as calcyclin/2A9/5B10/PRA)
and S100A4 (also known as pEL98/mtsl/p9Ka/18A2/42A/calvas-
culin/FSP1/CAPL) have been reported to be involved in invasion
and metastasis of cancer cells.
S100A6 was initially identified as mRNA preferentially
expressed in proliferating rather than quiescent cells (Calabretta 
et al, 1986; Jackson-Grusby et al, 1987). It has been shown that
increased S100A6 expression is associated with metastatic pheno-
type of NIH-3T3 cells (Guo et al, 1990) and the metastatic behav-
iour of human melanoma cells (Weterman et al, 1992; 1993).
S100A4 has been isolated by subtractive hybridization of non-
metastatic cells from metastatic mouse mammary adenocarcinoma
cells (Ebralidze et al, 1989). Rat epithelial cells transfected with
S100A4 cDNA showed metastatic capacity in syngeneic rats upon
injection in the mammary fat pad (Davies et al, 1993). Strong
evidence supporting a role for S100A4 in metastasis was obtained
in experiment where ribozyme-induced inhibition of S100A4
expression reversed the in vivo metastatic phenotype of human
osteosarcoma cells (Maelandsmo et al, 1996).
By immunohistochemical analysis, we have previously shown
that S100A6 expression in human colorectal adenocarcinomas is
significantly correlated with two clinical parameters, lymphatic
permeation and Duke’s tumour status (Komatsu et al, 2000).
Although there have been several reports on S100A6 and S100A4
expression in human cancer tissues, their expression levels have
been measured semiquantitatively by Northern blot analysis or by
immunohistochemistry. In the present study, we examined their
protein expression levels quantitatively by Western blot analysis in
human primary colorectal adenocarcinomas, adjacent normal
colorectal mucosa and liver metastases. By parallel immunohisto-
chemical staining, comparison of the expression patterns of
S100A6 and Ki-67 was made between primary lesions and liver
metastases and a unique S100A6 expression pattern was found in
liver metastases.
MATERIALS AND METHODS
Surgical specimens
Fresh human tissues (primary colorectal adenocarcinoma, adjacent
normal colorectal mucosa and liver metastasis from specimens
resected for carcinoma) were collected from patients undergoing
surgical resection in our hospital. Adjacent normal colorectal
mucosa specimens were obtained from the sites approximately
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immediately stored at –80° C for Western blotting (33 specimens)
or fixed with 10% formalin in phosphate-buffered saline (PBS) for
immunohistochemistry (58 specimens). Histopathological confir-
mation of surgical specimens for Western blotting was performed
by pathologists.
Preparation of tissue extracts
Frozen surgical specimens were thawed, minced with scissors,
crushed in a solution consisting of 0.05 M Tris-HCl, pH 6.8, 2%
(w/v) SDS, 6% (v/v) β -mercaptoethanol and 10% (w/v) glycerol
using polytron and centrifuged at 15 000 g for 10 min. The super-
natant was used immediately or stored frozen at –80° C for
immunoblot analysis.
SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
and Western blot analysis
SDS-PAGE was performed as described by Laemmli (1970).
Protein samples were electrophoresed on 15% polyacrylamide gel
under reducing conditions. The resolved proteins were electro-
phoretically transferred to PVDF (polyvinylidene difluoride)
membrane (Matsudaira, 1987). S100A6 and S100A4 were
detected using monoclonal anti-pig S100A6 antibody (mAbA6)
(Sigma, St. Louis, MO, USA) and rabbit anti-mouse S100A4 anti-
serum (polyAbA4), respectively. Actin was detected with mouse
monoclonal antibody to pan-actin (Anti-Actin: Boehringer
Mannheim, Mannheim, Germany). MAbA6 cross-reacts with
human, bovine, rabbit and rat S100A6 and does not react with
S100A2, S100A1 and S100B. Bovine S100A1 and bovine S100B
were obtained from Sigma. Anti-mouse IgG (H+L) AP conjugate
or anti-rabbit IgG (Fc) AP conjugate and BCIP/NBT Color
Substrate (Promega, Madison, WI, USA) were used for alkaline
phosphatase detection. Protein concentration was determined by
protein assay (Bio-Rad, Richmond, CA, USA). Protein expression
levels were quantitatively estimated by densitometric scanning
using a 1200 dpi flat-bed scanner with NIH Image 1.55f. S100A6
and S100A4 protein concentrations were normalized to actin level
and expressed as densitometric ratio.
Immunohistochemical staining
Four micrometre sections from formalin-fixed, paraffin-embedded
tissues were mounted on poly-L-lysine-coated slides. They were
then air-dried and deparaffinized. Immunohistochemical staining
was performed according to the method reported previously
(Komatsu et al, 2000). Briefly, after blocking non-specific binding
sites with 2% normal horse serum, the sections were incubated with
mAbA6 or monoclonal anti-Ki-67 antibody (MIB-1: Immunotech,
Westbroak, ME, USA). Then they were treated with biotinylated
horse anti-mouse IgG (Vector, Burlingame, CA, USA) and subse-
quently detected with an avidin-biotin system using 0.025% 3,3′ -
diaminobenzidine tetrahydrochloride as a chromogen. The sections
were lightly counterstained with Mayer’s haematoxylin.
Evaluation of degree of antibody reactivity
The degree of monoclonal anti-S100A6 or anti-Ki-67 antibody
reactivity with each tissue section was scored by percentage of
stained adenocarcinoma cells in the section. In this study, adeno-
carcinoma specimens with more than 50% stained cells were
defined as ‘Positive’. Three persons independently judged the
stained cells.
Statistical analysis
The χ 2 test and Student’s t-test were used for statistical analyses.
Correlations between S100A6 and S100A4 expressions were
checked by the Pearson’s correlation coefficient on a per-case
basis.
RESULTS
Western blotting of S100A6 and S100A4 in human
colorectal adenocarcinomas
We first subjected recombinant rabbit S100A6, recombinant
mouse S100A4, bovine S100A1, bovine S100B and human
colorectal adenocarcinoma lysate to SDS-PAGE in order to
examine whether mAbA6 and poly AbA4 specifically recognize
S100A6 and S100A4, respectively. As shown in Figure 1, S100A6
ran faster than S100A4 in SDS-PAGE. Both antibodies specifi-
cally recognized the corresponding antigens and did not cross-
react with each other. In tumour lysates, single bands were
observed at the same positions as recombinant proteins.
The expression levels of S100A6 and S100A4 proteins in paired
samples of human colorectal adenocarcinoma (T) and adjacent
normal colorectal mucosa (N) from a patient were compared by
Western blot analysis. Figure 2A shows S100A6 (upper column),
S100A4 (lower column) and actin protein expressions of paired N
and T from 12 cases. In 11 of 12 and seven of 12 cases, S100A6
and S100A4 expression levels were higher in T than in N, respec-
tively. Average S100A6 level of T was significantly higher than
that of N, whereas average S100A4 level of T was not (Figure 2B).
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Figure 1 Specificity of anti-S100A6 and anti-S100A4 antibodies. The
recombinant rabbit S100A6 (50 ng), recombinant mouse S100A4 (50 ng),
bovine S100A1 (50 ng), bovine S100B (50 ng) and human colorectal
adenocarcinoma lysate (1 µ g) were run on SDS-PAGE and blotted onto
PVDF membrane. The membrane was cut in half and Western blotting was
performed using mAbA6 (1:500) or poly AbA4 (1:1000). Arrows indicate
positions of migration of S100A6 and S100A4 proteins. Positions of the
molecular weight standards (in kDa) are indicatedExpression of S100A6 in primary human colorectal
adenocarcinomas and liver metastases
Three sets of matched samples, i.e. primary colorectal adenocarci-
noma (T), adjacent normal mucosa (N) and liver metastasis (M)
were collected from three cases and the expression of S100A6
protein was compared quantitatively by Western blot analysis
(Figure 3A). As shown in Figure 3B, S100A6 expression levels
were higher in M than in T in two of three cases.
Comparison of the immunohistochemical staining
patterns between S100A6 and Ki-67 in primary human
colorectal adenocarcinomas and liver metastases
In order to examine the expression of S100A6 at the histological
level, we performed immunohistochemical analysis using
formalin-fixed paraffin-embedded surgical specimens and
mAbA6. As previously reported, S100A6 was stained diffusely in
whole cytoplasms in both primary colorectal adenocarcinomas and
metastatic nodules in the liver (Komatsu et al, 2000). The staining
was abolished when an adjacent serial section was incubated with
mAbA6 that had been previously absorbed with excess recombi-
nant rabbit S100A6 protein, and further abolished by incubating
with normal mouse IgG1 (data not shown). Immunohistochemical
analysis demonstrated that 23 of 42 (55%) primary colorectal
adenocarcinoma and 15 of 16 (94%) metastatic nodules in the liver
specimens were mAbA6-positive. We next compared the immuno-
histochemical staining pattern of S100A6 with that of Ki-67 in
these tissues. Ki-67 is a growth marker which is present in the
nuclei (especially nucleoli) of growing normal and tumour cells,
although its function is still obscure (Gerdes et al, 1983). Figure 4
shows typical patterns of S100A6 and Ki-67 staining in serial
sections of primary colorectal adenocarcinoma and liver metas-
tasis. S100A6 staining was more intense in the invading fronts
with structural atypia than in central portions with glandular struc-
ture of the primary adenocarcinomas (Figure 4A), while Ki-67
staining pattern was similar in these two portions (Figure 4B).
Eighty five percent (35/41) of primary colorectal adenocarcinoma
specimens were stained as mAbA6-positive in the invading fronts,
whereas 27% (11/41) of specimens were stained as mAbA6-posi-
tive in central portions of the carcinomas (Figure 5). Only 12%
(5/41) specimens had positive staining in both central portions and
invading fronts. On the other hand, the percentages of Ki-67-
positive adenocarcinoma specimens were similar in both portions
(Figure 5).
In liver metastases, S100A6 staining was also more intense in
the invading fronts than in central portions (Figure 4C), while Ki-
67 staining pattern did not show such a tendency (Figure 4D).
Ninety four percent (15/16) of liver metastasis specimens were
stained as mAbA6-positive in the invading fronts, whereas 19%
(3/16) of liver metastasis specimens were stained as mAbA6-
positive in central portions (Figure 5). Only 13% (2/16) had posi-
tive staining in both central portions and invading fronts. On the
other hand, Ki-67 staining pattern in the invading fronts of liver
metastasis was similar to that in central portions (Figures 4D and 5).
The differences between central portions and invading fronts
were statistically significant in both primary and metastatic lesions
of colorectal adenocarcinomas (P < 0.0001).
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Figure 2 S100A6 and S100A4 expressions in human primary colorectal
adenocarcinomas and adjacent normal mucosa. (A) Western blot analyses of
S100A6 and S100A4. Tissue extracts (1 µ g) were run on SDS-PAGE and
blotted onto PVDF membrane. S100A6 and S100A4 immunoblots in normal
mucosa (N) and primary colorectal adenocarcinomas (T) in paired samples
from 12 cases are shown (upper column). Actin immunoblots are also shown
(lower column). Arrows indicate positions of S100A6, S100A4 and actin. 
(B) S100A6 and S100A4 expression levels in paired normal mucosa (N) and
adenocarcinomas (T). Vertical bars indicate means ± SE. NS = not significant
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Figure 3 S100A6 expression in human primary colorectal
adenocarcinomas and liver metastases. (A) Western blot analysis of the
S100A6. Matched primary adenocarcinoma (T), adjacent normal mucosa (N)
and liver metastasis (M) tissue extracts (1 µ g) from three cases were run on
SDS-PAGE as described in the legend of Figure 2A. S100A6 immunoblot
(upper column) and actin immunoblot (lower column) are shown. Arrows
indicate positions of S100A6 and actin. (B) Comparison of S100A6
expression levels. The densitometric ratios (S100A6/actin) of matched N, T
and M samples from three cases in Figure 3A are shownDISCUSSION
Histopathological confirmation of surgical specimens for Western
blotting revealed that primary colorectal adenocarcinoma speci-
mens consisted of adenocarcinoma cells (60–70%), stromal cells
(20–30%) and normal mucosal tissues (5–10%) and that liver
metastasis specimens were made up of adenocarcinoma cells
(70–80%) and stromal cells (20–30%). Almost no normal liver
cells were observed in liver metastasis specimens. Normal mucosa
specimens consisted of only non-tumorous mucosal tissues.
By Western blot analysis, we found that the expression level of
S100A6 protein was significantly higher (about × 2.3) in human
colorectal adenocarcinomas (T) than in paired adjacent normal
mucosa (N) (Figures 2A and 2B). Although average S100A4 level
in T was 1.6 times higher than in N, this difference was not statis-
tically significant (Figure 2B). If case 9 was excluded from the
samples, average S100A4 level in T was 2.4 times higher than 
in N. However, this difference still remained not significant. In
contrast, Takenaga et al (1997) found that S100A4 mRNA expres-
sion is significantly higher in human colorectal adenocarcinomas
than in normal mucosa. Because a considerable variation in
S100A4 expression levels was observed in patients with primary
colorectal adenocarcinoma (Figure 2A), this discrepancy may be
due to variations in characteristics of patients. Concerning the
expression levels of S100A6 and S100A4 in cancer tissues,
Maelandsmo et al (1997) showed that S100A6 mRNA expression
levels were in general higher in human metastatic melanomas than
in the benign naevi, whereas there were no clear differences in
S100A4 expression levels between these two tissues. Although
cancer tissue is different, their results are similar to ours.
When the correlation between expressions of S100A6/actin and
S100A4/actin in normal mucosa and in adenocarcinoma samples
was analysed by Pearson’s correlation coefficient tests on a per-
case basis, no appreciable correlation could be found in both
samples (data not shown). Although these two genes are known to
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Figure 4 Immunohistochemical staining patterns of S100A6 and Ki-67 in human primary colorectal adenocarcinoma and liver metastasis. Staining was
performed as described in the text. (A) Primary adenocarcinoma stained with mAbA6. (B) Primary adenocarcinoma stained with anti-Ki-67 antibody. (C) Liver
metastasis stained with mAbA6. (D) Liver metastasis stained with anti-Ki-67 antibody. A and B or C and D are adjacent serial sections. Magnification × 20.
Scale bars = 100 µ m.
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Figure 5 Percentages of S100A6 and Ki-67 immunopositive primary and
liver metastatic human colorectal adenocarcinomas. C = central portions of
tumours. I = Invading fronts of tumours. Percentage positive
adenocarcinomas = % of adenocarcinoma specimens with more than 50%
stained cellscolocalize on the chromosome 1q21 (Schäfer et al, 1995), this
suggests that expression of these two genes may be differentially
regulated.
In three sets of matched samples of primary colorectal adeno-
carcinoma and the liver metastasis, S100A6 expression levels
were higher in metastasis than in primary tumour in only two of
three cases. This result suggests that metastatic nodules in the liver
do not always consist of highly S100A6-positive carcinoma cells.
Therefore, the distribution of S100A6-positive carcinoma cells
was examined in primary adenocarcinomas and liver metastases
by immunohistochemical analysis. In primary adenocarcinomas,
S100A6 was significantly more intensely immunostained in the
invading fronts with structural atypia than in central portions with
glandular structure (Figures 4A and 5), whereas Ki-67 staining
pattern was similar in these two portions (Figures 4B and 5). Since
S100A6 expression has been considered to be involved in cell
growth, these results were unexpected. However, a dissociation
between S100A6 expression and cell growth was shown in human
endometrial adenocarcinoma cell lines in which phorbor esters
inhibit cell growth but enhance S100A6 expression (Gong et al,
1992). We observed that deeply invaded adenocarcinoma cells
consisting of single cells, and the carcinoma cells invaded into
lymphatic vessels, were intensely stained with mAbA6. The
infiltrating neutrophils and macrophages in the stroma were also
mAbA6-positive (data not shown). Furthermore, Guo et al (1990)
reported that S100A6 expression was higher in metastatic H-ras
transformed NIH 3T3 cells than in non-metastatic cells. Weterman
et al (1992) showed that S100A6 expression was elevated in
highly metastatic human melanoma cell lines as compared with
low metastatic ones. These results suggest that S100A6 is involved
in the invasive process of human colorectal adenocarcinoma cells.
Carcinoma cells with high metastatic potentials in the primary
lesion are often dissociated or dedifferentiated at the invading
fronts (Ono et al, 1996). These dissociated carcinoma cells invade
the surrounding tissues, metastasize to the liver and proliferate to
form metastatic nodules. Carcinoma cells metastasized to the liver
regain cell–cell adhesiveness, form glandular structure again and
are often dissociated at the invading fronts of metastatic nodules.
In this study, the dissociated carcinoma cells were more strongly
mAbA6-positive as compared to the cells with glandular structure
at the centre of the primary lesions (Figure 4A). Therefore, we
expected that all of the carcinoma cells in metastatic nodules in the
liver were strongly mAbA6-positive. To our surprise, however, we
found that S100A6 was more intensely stained in the invading
fronts with structural atypia than in central portions with glandular
structure of the metastatic nodules (Figure 4C), whereas Ki-67
staining was similar in these two portions (Figure 4D). This differ-
ence in S100A6 staining was statistically significant (Figure 5: 
P < 0.0001). Normal liver cells were not stained at all with
mAbA6. These results suggest that S100A6 expression in
metastatic adenocarcinoma cells is reversible and that S100A6
expression levels are reduced when carcinoma cells regain
cell–cell adhesiveness at the central portions of metastatic nodules.
It has been reported that Ki-67 expression in liver metastases is
higher (De Jong et al, 1998) or lower (Saarnio et al, 1998) than in
primary tumours and that Ki-67 expression levels are not signifi-
cantly different between these two tissues (Thomas et al, 1998). In
the present study, Ki-67 expression was significantly higher in
liver metastases than in primary lesions (Figure 5: P = 0.002).
Variations in characteristics of patients, tumour heterogeneity and
immunohistochemical assessments are possible explanations for
this discrepancy in the results.
The immunohistochemical staining pattern of S100A4 in human
colorectal adenocarcinomas was reported by Takenaga et al
(1997). They showed that most of the adenocarcinoma cells that
invaded deeply were much more intensely stained than those in 
the mucosal region. Although staining patterns of S100A6 and
S100A4 appeared similar in primary adenocarcinomas, their func-
tional roles in the tumour remain to be elucidated. Further studies
are in progress in our laboratory to provide evidence for a
causative role of S100A6 in the invasive potential of human
colorectal adenocarcinoma cells.
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